<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="54114">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02401659</url>
  </required_header>
  <id_info>
    <org_study_id>T431 v 2.0</org_study_id>
    <nct_id>NCT02401659</nct_id>
  </id_info>
  <brief_title>Importance of Patient´s Satisfaction With Telemedicine Based on Monitoring Systems</brief_title>
  <acronym>VALIOSA</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Valiosa is a national, multicenter and prospective post market study. The objectives of the
      study are to generate and validate an instrument to evaluate patient and clinician's
      satisfaction with remote monitoring and to create awareness of the importance of remote
      monitoring among patients, physicians and decision makers.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">January 2016</completion_date>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Satisfaction with telemedicine measured by the questionnaire in evaluation</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with medical treatment measured by visual analog scale</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life measured by SF-36</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Arrythmia</condition>
  <arm_group>
    <arm_group_label>naïve with CareLink</arm_group_label>
    <description>patients with a first implant of an implanted cardiac device naïve in CareLink or patients with a refill who have not used CareLink until the implant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>users of CareLink</arm_group_label>
    <description>patients with an implanted cardiac device who have used CareLink for more than one year</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CareLinK</intervention_name>
    <arm_group_label>naïve with CareLink</arm_group_label>
    <arm_group_label>users of CareLink</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an implantable cardiac device and using CareLink® program for the remote
        monitoring of the device.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients- naïve in CareLink®:

               -  First implant patients, who initiate in CareLink®

               -  Replacements patients who initiate in CareLink.

          2. Long term users in CareLink®: patients in CareLink for more than a year.

          3. Both male and female

          4. More than 18 years old.

          5. Be at the disposal of using CareLink monitoring system.

          6. Complete informed consent and accept the conditions of CareLink system.

        Exclusion Criteria:

          1. Less than 18 years old

          2. Suffer from any menthal pathology who prevents the patient to collaborate in the
             study.

          3. Be unable to understand or answer questionnaires in Spanish.

          4. Deny to continue in the study.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitario de Araba</name>
      <address>
        <city>Vitoria</city>
        <state>Basque Country</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Martínez-Ferrer, PhD</last_name>
      <phone>+34 945 00 70 00</phone>
    </contact>
    <investigator>
      <last_name>José Martínez-Ferrer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <state>Catalonia</state>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier Viñolas, PhD</last_name>
      <phone>+34 932 91 90 00</phone>
    </contact>
    <investigator>
      <last_name>Xavier Viñolas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Infanta Leonor</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roberto Muñoz, PhD</last_name>
      <phone>+34 911 91 80 00</phone>
    </contact>
    <investigator>
      <last_name>Roberto Muñoz, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jorge Silvestre, PhD</last_name>
      <phone>91 727 70 00</phone>
    </contact>
    <investigator>
      <last_name>Jorge Martínez-Ferrer, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <lastchanged_date>March 24, 2015</lastchanged_date>
  <firstreceived_date>March 17, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>remote monitoring</keyword>
  <keyword>satisfaction</keyword>
  <keyword>telemonitoring</keyword>
  <keyword>quality of life</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
